- Conditions
- Hyperopia
- Interventions
- MEL 80 Hyperopic LASIK Treatment
- Device
- Lead sponsor
- Carl Zeiss Meditec, Inc.
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 189 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2004 – 2008
- U.S. locations
- 6
- States / cities
- San Diego, California • Greenwood Village, Colorado • Kansas City, Missouri + 3 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 913–936
of 1,021
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Burns, Hypertrophic Scar
- Interventions
- Luminis ultrapulse fractional ablative carbon dioxide laser, 0.5mm punch biopsy
- Procedure
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2025
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Myopia
- Interventions
- SMILE, LASIK
- Procedure
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 22 Years to 59 Years
- Enrollment
- 44 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2021
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Diabetic Macular Edema
- Interventions
- intravitreal injection of ranibizumab, peripheral laser, intravitreal injection of triamcinolone acetonide, macular laser
- Drug · Procedure
- Lead sponsor
- Retina Associates of Florida, P.A.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 22 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2011
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- Low Level Laser Therapy, Osteoarthritis, Family Medicine, Pain Management, Integrative Medicine
- Interventions
- Phoenix Thera-Lase System, SHAM Phoenix Thera-Lase System
- Device
- Lead sponsor
- David Moss
- Federal
- Eligibility
- 18 Years and older
- Enrollment
- 83 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2025
- U.S. locations
- 1
- States / cities
- Nellis Air Force Base, Nevada
- Conditions
- Presbyopia
- Interventions
- The Raindrop Near Vision Inlay
- Device
- Lead sponsor
- ReVision Optics, Inc.
- Industry
- Eligibility
- 35 Years to 65 Years
- Enrollment
- 373 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2016
- U.S. locations
- 11
- States / cities
- Camarillo, California • Laguna Hills, California • Newport Beach, California + 7 more
- Conditions
- Head and Neck Cancer
- Interventions
- HPPH
- Drug
- Lead sponsor
- Roswell Park Cancer Institute
- Other
- Eligibility
- 18 Years to 120 Years
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2015
- U.S. locations
- 1
- States / cities
- Buffalo, New York
- Conditions
- Prostate Cancer
- Interventions
- Photodynamic Therapy (PDT), Verteporfin Injection
- Device · Drug
- Lead sponsor
- SpectraCure AB
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 43 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Prostate Cancer
- Interventions
- MR-guided laser focal therapy
- Device
- Lead sponsor
- HALO Diagnostics
- Industry
- Eligibility
- 45 Years to 90 Years · Male only
- Enrollment
- 1,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2036
- U.S. locations
- 1
- States / cities
- Indian Wells, California
- Conditions
- Proliferative Diabetic Retinopathy
- Interventions
- Propranolol
- Drug
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin
- Conditions
- Myopia
- Interventions
- Low-level Red Light Therapy Device
- Device
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 8 Years to 13 Years
- Enrollment
- 90 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2027
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Urinary Incontinence, Stress Urinary Incontinence, Urge Incontinence
- Interventions
- Hybrid Fractional Laser
- Device
- Lead sponsor
- Sciton
- Industry
- Eligibility
- 30 Years to 75 Years · Female only
- Enrollment
- 51 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2019
- U.S. locations
- 5
- States / cities
- Los Gatos, California • Pensacola, Florida • Charlotte, North Carolina + 2 more
- Conditions
- Acne Vulgaris, Scar
- Interventions
- Microneedling, Fractional non-ablative 1,540nm laser
- Device
- Lead sponsor
- Boston University
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Precancerous/Nonmalignant Condition
- Interventions
- aminolevulinic acid, laser therapy
- Drug · Procedure
- Lead sponsor
- Roswell Park Cancer Institute
- Other
- Eligibility
- 18 Years to 120 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 1
- States / cities
- Buffalo, New York
- Conditions
- Genitourinary Syndrome of Menopause
- Interventions
- Optical coherence tomography (OCT)
- Diagnostic Test
- Lead sponsor
- University of California, Irvine
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 50 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2027
- U.S. locations
- 1
- States / cities
- Irvine, California
- Conditions
- Varicose Veins
- Interventions
- Varithena®, FDA-approved Endothermal Ablation (ETA) systems
- Drug · Device
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 43 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 9
- States / cities
- Darien, Connecticut • Washington D.C., District of Columbia • Houma, Louisiana + 6 more
- Conditions
- Anisometropia, Hyperopia, High Myopia, Amblyopia Isometropic, Amblyopia Bilateral, High Astigmatism
- Interventions
- Photorefractive keratectomy
- Procedure
- Lead sponsor
- Baylor College of Medicine
- Other
- Eligibility
- 2 Years to 17 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2024
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Keloid
- Interventions
- The Lutronic electronic carbon dioxide (eCO2) Plus laser system, Intralesional Triamcinolone Acetonide
- Device · Drug
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- POH
- Interventions
- PiQo4 Laser System
- Device
- Lead sponsor
- Focus Medical, LLC
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 8 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2022
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Diabetic Macular Edema
- Interventions
- bevacizumab, PASCAL Endpoint Management (EpM) laser treatment
- Drug · Device
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2027
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Poikiloderma of Civatte, Dyschromia, Pigmentation Disorders, Telangiectasia, Photosensitivity Disorders
- Interventions
- 532 nm KTP laser
- Device
- Lead sponsor
- Cutera Inc.
- Industry
- Eligibility
- 35 Years to 65 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 1
- States / cities
- Edina, Minnesota
- Conditions
- Actinic Keratosis
- Interventions
- 5-ALA plus Blu-Light, 5-FU, Imiquimod or treatment with cryotherapy
- Drug
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 18 Years to 95 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Otorhinolaryngologic Surgical Procedures, Laser Therapy
- Interventions
- THRIVE, Endotracheal tube
- Device
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Choledocholithiasis, Pancreatic Duct Stone
- Interventions
- Laser lithotripsy with low-wattage holmium laser, Electrohydraulic lithotripsy
- Device
- Lead sponsor
- Rush University Medical Center
- Other
- Eligibility
- 19 Years to 85 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Chicago, Illinois